GlassScriptPhysician profile
Madeline A Hunt
NPI 1063606499
$747.76
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2022: $20.02.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $127.00 | 2019 | |
| Lilly USA, LLC | $125.33 | 2019 | |
| Mannkind Corporation | $111.80 | 2019 | |
| Horizon Therapeutics Plc | $53.46 | 2019 | |
| Amgen INC. | $44.43 | 2019 | |
| Arbor Pharmaceuticals, INC. | $40.93 | 2019 | |
| Genentech USA, INC. | $40.62 | 2019 | |
| Amarin Pharma, INC. | $32.60 | 2019 | |
| Glaxosmithkline, LLC. | $26.20 | 2019 | |
| Allergan, INC. | $24.91 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $23.62 | 2019 | |
| Merck Sharp & Dohme LLC | $23.29 | 2019 | |
| Abbvie INC. | $20.02 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.56 | 2019 | |
| Shire North American Group INC | $13.64 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.01 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.34 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeline Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.